cardiac-surgery
(4)
Edwards Lifesciences and the art of thinking smaller
An engineer wanted to build an artificial heart. A surgeon suggested starting with a valve. Nearly seven decades later, Edwards is still finding room to grow by narrowing its focus.
Renibus Therapeutics and the art of the second chance
A kidney-drug acquisition cost $250,000 upfront. A cardiac-surgery trial missed its target. Renibus now has to show which promising ideas deserve another experiment.
Spectrum Medical wants to connect every beat of heart surgery
Pumps, disposable circuits and patient records all meet in Spectrum Medical’s Quantum range. Its expansion shows the appeal of joining them together - and the scrutiny that comes with supplying life-support technology.
CardioRenal Systems, Inc.
CardioRenal Systems is a Milford, Massachusetts medical device company developing RenalPro (marketed as RenalGuard outside the US), an automated fluid-management system that prevents acute kidney injury in high-risk hospital settings. By monitoring urine output in real time and matching IV hydration in milliliter increments, the system keeps patients balanced during cardiac surgery, catheter procedures, and ICU care. RenalPro holds FDA Breakthrough Device Designation and a CE Mark, and in a 220-patient randomized UK trial cut AKI by 52% versus standard care.